A new study suggests that probiotics supplementation during early pregnancy may help reduce the risk of recurrent spontaneous preterm delivery (sPTD). In a multicentre clinical trial, pregnant women… read more.
Flu vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research published in… read more.
A new blood test, using a marker for late-stage Alzheimer’s disease, could offer a clinically relevant dementia diagnosis with fewer false positives, according to researchers at Lund University… read more.
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
The European Medicines Agency (EMA) has launched three major new features of PRIME, the Agency’s scheme to enhance support for the development of medicines targeting an unmet medical… read more.
The EU’s drug regulator, the European Medicines Agency (EMA), has issued recommendations for the influenza virus strains that vaccine manufacturers should include from autumn 2026. Every year, EMA… read more.
The European Medicines Agency’s key human medicines committee (CHMP) has recommended five medicines for approval at its March 2026 meeting. This brings to 23 the total number of… read more.
The European Medicines Agency (EMA) has given its approval for six new medicines, with another nine products receiving extensions for their therapeutic indications. The decisions came as the… read more.
Scientists have discovered a biomarker that could be used to identify Parkinson’s before extensive brain damage has occurred. The finding, by a team at Chalmers University of Technology,… read more.
Researchers have shown for the first time that maternal antibodies are found not only in the blood of newborns, but also in the nasal mucosa. The international study,… read more.
The European Medicines Agency (EMA) has released a statement designed to clear up any remaining uncertainty about the use of paracetamol. In the EU, the drug watchdog says,… read more.
A new AI-powered model has been shown to advance treatment planning for spinal metastasis by calculating patients’ chances of survival. Doctors can then make informed decisions about, for… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
